Published in Int J Stroke on November 22, 2011
Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview. Neurol Sci (2014) 1.42
Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke. PLoS One (2013) 1.02
Reasons for low thrombolysis rate in a Norwegian ischemic stroke population. Neurol Sci (2014) 0.77
The Itemized NIHSS Scores Are Associated With Discharge Disposition in Patients With Minor Stroke. Neurohospitalist (2016) 0.75
Minor Stroke and Transient Ischemic Attack: Research and Practice. Front Neurol (2016) 0.75
Of people admitted within 2 h of mild/improving stroke, 31% do not receive rtPA, although many of these people have poor outcomes. Evid Based Med (2012) 0.75
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology (2001) 4.84
Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology (2010) 4.56
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA (2000) 3.17
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke (2004) 2.97
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology (2005) 2.86
The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56
Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol (2006) 2.17
Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke (2005) 2.03
Outcome of stroke with mild or rapidly improving symptoms. Stroke (2007) 1.89
Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology (2006) 1.68
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
What is a minor stroke? Stroke (2010) 1.65
Why are eligible thrombolysis candidates left untreated? Am J Prev Med (2006) 1.45
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis (2008) 1.23
Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke (2006) 1.20
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology (1999) 1.10
Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital. Acta Neurol Scand (2009) 1.03
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72
Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep (2005) 8.15
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2010) 3.49
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke (2004) 2.76
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Stroke literacy in Central Harlem: a high-risk stroke population. Neurology (2009) 2.06
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair (2007) 1.86
The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis (2006) 1.83
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke (2010) 1.72
Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Effectiveness of a universal drug abuse prevention approach for youth at high risk for substance use initiation. Prev Med (2003) 1.62
Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke (2003) 1.61
Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52
Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48
Prevalence and quality of endodontic treatment in the Northern Manhattan elderly. J Endod (2007) 1.45
Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke (2004) 1.42
Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension (2012) 1.41
Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med (2012) 1.37
Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med (2014) 1.34
Improvement after constraint-induced movement therapy: recovery of normal motor control or task-specific compensation? Neurorehabil Neural Repair (2012) 1.33
Research data collection methods: from paper to tablet computers. Med Care (2012) 1.33
The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32
Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke (2012) 1.32
Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke (2004) 1.32
Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32
Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc (2009) 1.30
Birth and adult residence in the Stroke Belt independently predict stroke mortality. Neurology (2009) 1.28
Periodontal bacteria and hypertension: the oral infections and vascular disease epidemiology study (INVEST). J Hypertens (2010) 1.28
Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26
Design of a family study among high-risk Caribbean Hispanics: the Northern Manhattan Family Study. Ethn Dis (2007) 1.25
Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke (2006) 1.25
The vascular effects of infection in Pediatric Stroke (VIPS) Study. J Child Neurol (2011) 1.23
Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart (2012) 1.23
Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis (2007) 1.23
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Leukocyte count is associated with reduced endothelial reactivity. Atherosclerosis (2005) 1.21
Stochastic approximation with virtual observations for dose-finding on discrete levels. Biometrika (2009) 1.21
Septal pouch in the left atrium and risk of ischemic stroke. JACC Cardiovasc Imaging (2010) 1.20
Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovasc Imaging (2008) 1.18
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17
Relation between socioeconomic status, race-ethnicity, and left ventricular mass: the Northern Manhattan study. Hypertension (2004) 1.15
Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke (2010) 1.14
The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol. Stroke (2013) 1.14
Social determinants of physical inactivity in the Northern Manhattan Study (NOMAS). J Community Health (2010) 1.14
Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke (2013) 1.14